# Boston Scientific Acquires Penumbra in Major Medtech Deal Driving H1 2026 Record Activity

> ma · REPORTED · 2026-06-17

Boston Scientific's acquisition of Penumbra, alongside Danaher's acquisition of Masimo, drove medtech M&A deal volumes and values above the first half of 2025, according to MedTech Dive reporting from June 17, 2026. The deals reflect continued consolidation in high-growth medtech segments including neurovascular and patient monitoring.

About Boston Scientific / Penumbra: Penumbra is a medical device company specializing in neuro and vascular access technologies used to treat stroke and other vascular conditions in hospital settings.

- Company: Boston Scientific / Penumbra
- Sector: medtech
- Primary source: https://www.medtechdive.com/topic/medical-devices/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.